Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-06-048981
Filing Date
2006-11-20
Accepted
2006-11-20 10:46:50
Documents
4
Period of Report
2006-12-18
Effectiveness Date
2006-11-20

Document Format Files

Seq Description Document Type Size
1 v058081def14a.htm DEF 14A 586027
2 GRAPHIC v058081def14a001.jpg GRAPHIC 8700
3 GRAPHIC v058081def14a002.jpg GRAPHIC 8700
4 GRAPHIC v058081def14a003.jpg GRAPHIC 8700
  Complete submission text file 0001144204-06-048981.txt   624111
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 333-61610 | Film No.: 061228635
SIC: 2836 Biological Products, (No Diagnostic Substances)